Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
Journal
Journal of Translational Medicine
Journal Volume
21
Journal Issue
1
Date Issued
2023-10-11
Author(s)
Chang, Kai-Hsiung
Lee, Cheng-Fan
Chao, Yen-Hsiang
Lu, Shih-Yu
Wu, Tzu-Fan
Liang, Sung-Tzu
Lin, Chih-Yu
Lin, Yuan Chi
Huang, William J
Lin, Tzu-Ping
Ku, Ming-Hsuan
Chung, Hsiao-Jen
Chang, Yen-Hwa
Liao, Chun-Hou
Yu, Chih-Chin
Chung, Shiu-Dong
Tsai, Yao-Chou
Wu, Chia-Chang
Chen, Kuan-Chou
Ho, Chen-Hsun
Hsiao, Pei-Wen
Abstract
Currently, there are no accurate markers for predicting potentially lethal prostate cancer (PC) before biopsy. This study aimed to develop urine tests to predict clinically significant PC (sPC) in men at risk.
Subjects
Active surveillance; Aggressive; Diagnosis; Liquid biopsy; Prediction
Publisher
BioMed Central Ltd
Type
journal article